Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Approach to the patient with anaplastic thyroid carcinoma.

Smallridge RC.

J Clin Endocrinol Metab. 2012 Aug;97(8):2566-72. doi: 10.1210/jc.2012-1314.

2.

Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.

Gómez Sáez JM, Jiménez-Fonseca P, Santamaría Sandi J, Capdevila Castillón J, Navarro González E, Zafón Llopis C, Ramón Y Cajal Asensio T, Riesco Eizaguirre G, Grande Pulido E, Galofré Ferrater JC.

Endocrinol Nutr. 2015 Mar;62(3):e15-22. doi: 10.1016/j.endonu.2014.11.006.

PMID:
25583658
3.

Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.

Nachalon Y, Stern-Shavit S, Bachar G, Shvero J, Limon D, Popovtzer A.

JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1128-32. doi: 10.1001/jamaoto.2015.2332.

PMID:
26512447
4.

Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.

Akaishi J, Sugino K, Kitagawa W, Nagahama M, Kameyama K, Shimizu K, Ito K, Ito K.

Thyroid. 2011 Nov;21(11):1183-9. doi: 10.1089/thy.2010.0332.

PMID:
21936674
5.

American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.

Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM; American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce..

Thyroid. 2012 Nov;22(11):1104-39. doi: 10.1089/thy.2012.0302.

PMID:
23130564
6.

Anaplastic thyroid cancer: prevalence, diagnosis and treatment.

Chiacchio S, Lorenzoni A, Boni G, Rubello D, Elisei R, Mariani G.

Minerva Endocrinol. 2008 Dec;33(4):341-57. Review.

PMID:
18923370
7.

Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy.

Foote RL, Molina JR, Kasperbauer JL, Lloyd RV, McIver B, Morris JC, Grant CS, Thompson GB, Richards ML, Hay ID, Smallridge RC, Bible KC.

Thyroid. 2011 Jan;21(1):25-30. doi: 10.1089/thy.2010.0220.

PMID:
21162687
8.

Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.

Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S.

World J Surg. 2012 Jun;36(6):1247-54. doi: 10.1007/s00268-012-1437-z.

PMID:
22311136
9.

Anaplastic thyroid carcinoma: palliation or treatment?

Wein RO, Weber RS.

Curr Opin Otolaryngol Head Neck Surg. 2011 Apr;19(2):113-8. doi: 10.1097/MOO.0b013e328343af3d. Review.

PMID:
21252667
10.

Investigation of the validity of UICC stage grouping of anaplastic carcinoma of the thyroid.

Ito Y, Higashiyama T, Hirokawa M, Fukushima M, Inoue H, Yabuta T, Tomoda C, Uruno T, Kihara M, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A.

Asian J Surg. 2009 Jan;32(1):47-50. doi: 10.1016/S1015-9584(09)60008-7.

11.

Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.

Wendler J, Kroiss M, Gast K, Kreissl MC, Allelein S, Lichtenauer U, Blaser R, Spitzweg C, Fassnacht M, Schott M, Führer D, Tiedje V.

Eur J Endocrinol. 2016 Dec;175(6):521-529.

PMID:
27926471
12.

[Differential diagnosis and strategy for the treatment of anaplastic thyroid carcinoma].

Suzuki S.

Nihon Rinsho. 2007 Nov;65(11):2079-86. Review. Japanese.

PMID:
18018574
13.

A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.

Busnardo B, Daniele O, Pelizzo MR, Mazzarotto R, Nacamulli D, Devido D, Mian C, Girelli ME.

J Endocrinol Invest. 2000 Dec;23(11):755-61.

PMID:
11194710
14.

Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors.

Ito K, Hanamura T, Murayama K, Okada T, Watanabe T, Harada M, Ito T, Koyama H, Kanai T, Maeno K, Mochizuki Y, Amano J.

Head Neck. 2012 Feb;34(2):230-7. doi: 10.1002/hed.21721.

PMID:
21500309
15.

Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma.

He X, Li D, Hu C, Wang Z, Ying H, Wu Y.

BMC Cancer. 2014 Apr 2;14:235. doi: 10.1186/1471-2407-14-235.

16.

[Radiation therapy in thyroid cancer].

Sun XS, Guevara N, Fakhry N, Sun SR, Marcy PY, Santini J, Bosset JF, Thariat J.

Cancer Radiother. 2013 Jun;17(3):233-43; quiz 255-6, 258. doi: 10.1016/j.canrad.2012.12.003. Review. French.

PMID:
23763764
17.

Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases.

Goffredo P, Thomas SM, Adam MA, Sosa JA, Roman SA.

Ann Surg Oncol. 2015 Dec;22(13):4166-74. doi: 10.1245/s10434-015-4742-6.

PMID:
26271394
18.

Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.

Jiménez-Fonseca P, Gómez Saez JM, Santamaria Sandi J, Capdevila J, Navarro Gonzalez E, Zafon Llopis C, Ramón Y Cajal Asensio T, Riesco-Eizaguirre G, Grande E, Galofré JC.

Clin Transl Oncol. 2017 Jan;19(1):12-20. doi: 10.1007/s12094-016-1506-0. Review.

PMID:
27048161
19.

Marginal treatment benefit in anaplastic thyroid cancer.

Haymart MR, Banerjee M, Yin H, Worden F, Griggs JJ.

Cancer. 2013 Sep 1;119(17):3133-9. doi: 10.1002/cncr.28187.

20.

Treatment of 37 patients with anaplastic carcinoma of the thyroid.

Kobayashi T, Asakawa H, Umeshita K, Takeda T, Maruyama H, Matsuzuka F, Monden M.

Head Neck. 1996 Jan-Feb;18(1):36-41.

PMID:
8774920

Supplemental Content

Support Center